首页> 外文会议>International Conference on Applications of Mathematics in Engineering and Economics >Prognostic Factors for the Presence of the Methastasis in Lymph Nodes and Organs in Bulgarien Patients with Colorectal Carcinoma
【24h】

Prognostic Factors for the Presence of the Methastasis in Lymph Nodes and Organs in Bulgarien Patients with Colorectal Carcinoma

机译:预后因子在保加利亚患者淋巴结患者淋巴结和器官中的存在性导致结直肠癌患者

获取原文

摘要

Colorectal carcinoma (CRC) is the third most common malignant tumor among all organ localizations and second most common cause of mortality in developed countries. CRC is divided into three main histological types according to the WHO classification: carcinomas, neuroendocrine neoplasms and mesenchymal tumors. The most common type is the adenocarcinoma and it is the subject of our study. In the present study, logistic regression was used to model the occurrence of metastasis in lymph nodes and organs, depending on anti-BRAF(V600E) antibody, anti-APC antibody, anti- MSH2 antibody, anti-SMAD antibody and anti-P53 antibodyin order to identify the statistically significant ones. The obtained models allow us to estimate the predicted probability of the occurrence of this complication by setting the individual values for the intensity and expression of the antibodies. The models were based on experimental data from histologically verified colorectal adenocarcinomas in a study of biopsy materials in the Clinic of General and Clinical Pathology, University Hospital "St. Marina" - Varna, Bulgaria.
机译:结肠直肠癌(CRC)是所有器官本地化的第三个最常见的恶性肿瘤和发达国家死亡率的第二个最常见的原因。根据世卫组织分类:癌,神经内分泌肿瘤和间充质肿瘤,CRC分为三种主要的组织学类型。最常见的类型是腺癌,它是我们研究的主题。在本研究中,逻辑回归用于模拟淋巴结和器官中转移的发生,这取决于抗BRAF(V600E)抗体,抗APC抗体,抗MSH2抗体,抗Smad抗体和抗P53抗体为了识别统计上有效的。所获得的模型允许我们通过设定抗体强度和表达的个体值来估计预测的这种并发症的可能性。该模型基于来自组织学验证结肠直肠腺癌的实验数据,在一般和临床病理学临床病理学,大学医院“St. Marina” - 瓦尔纳,保加利亚的活组织检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号